Moderna’s stock jumps after biotech raises sales outlook
The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026.
VolFlash analysisNot analysed
This event fell outside the real-time analysis window (published more than 6 hours ago), so no analysis was generated. Live events are analysed within a minute of publication.
Related guidesHow markets transmit
One email a day — don't miss the big ones
The 8 highest-severity events of the past 24h, with our read and source links. Unsubscribe anytime.
Published：2026-11-06 12:17:07 · Source：marketwatch · Automatically aggregated and analysed — verify against the original source.